Similarly, grapeseed procyanidin has demonstrated an inhibitory effect on NF-κB activity and MAPK/ERK pathway mediated YB-1 in ovarian cancer cells, suggesting its potential use as a chemo-sensitizer to overcome multidrug resistance in ovarian cancer patients (13). Here, YBX1 is linked to ovarian carcinoma.